Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_777a7d4b6d214f486f77cccc5afc193d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-186 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-576 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-576 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 |
filingDate |
2019-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37748e06c2ca4daafad0b1dc1f872a82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40b92589dfac96c11ada7c58c87f68c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dc3e9c03d69abbd52a24b6bdd0ee13b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a83b9fac27630c03f4a3e428a73eb5f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d99b892a330c96246a0be3315be7f7a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b72469e6ad93fa9b52cbf4ca8522f389 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01750f94cc5da30469776082b7607032 |
publicationDate |
2020-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2020308228-A1 |
titleOfInvention |
Peptide inhibitors of hcv ns3/4a protease comprising non-proteinogenic amino residues |
abstract |
Peptide inhibitors of activation of hepatitis C virus (HCV) NS3 protease are disclosed. They are analogs of the activation peptide HCV NS4 of residues 21-33 of SEQ ID NO: 2 and contain non-proteinogenic amino acids. Competitive binding studies showed the peptide analogs bind HCV NS3 protease at the activation site. |
priorityDate |
2019-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |